Association of quality of life measures with afamelanotide treatment in patients with erythropoietic protoporphyria and x-linked protoporphyria: A retrospective cohort study

Authors

Marissa S. Ceresnie, Henry Ford HealthFollow
Lindsey Mohney
Dayoung Ko, Henry Ford HealthFollow
Henry W. Lim, Henry Ford HealthFollow
Tasneem F. Mohammad, Henry Ford HealthFollow

Recommended Citation

Ceresnie MS, Mohney L, Ko D, Lim HW, and Mohammad TF. Association of quality of life measures with afamelanotide treatment in patients with erythropoietic protoporphyria and x-linked protoporphyria: a retrospective cohort study. J Am Acad Dermatol 2022.

Document Type

Article

Publication Date

10-13-2022

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

36244556

ePublication

ePub ahead of print